Chemical Identity and Structural Features

cis-4-Fluoropyrrolidin-3-ol hydrochloride (SKU C174216) is a saturated five-membered nitrogen heterocycle bearing two adjacent, stereospecifically defined substituents: a fluorine atom at the C-4 position and a hydroxyl group at the C-3 position in a cis (syn) relative configuration. The compound is supplied as its hydrochloride salt, which confers improved hygroscopic stability and aqueous solubility compared with the free base form.

The pyrrolidine ring is a privileged scaffold in drug design because it mimics the geometry of proline-containing peptides, provides a conformationally restricted sp³-rich framework, and is amenable to diverse N-functionalization. The introduction of a cis-vicinal fluorohydrin motif further distinguishes this building block: the fluorine atom modulates the ring pucker through the gauche effect, the hydroxyl group offers a handle for further derivatization or hydrogen-bond donation, and the two groups together define a precise three-dimensional presentation of pharmacophoric elements.

Role of Fluorine in Pyrrolidine-Based Medicinal Chemistry

Fluorine substitution on saturated heterocycles has become a cornerstone strategy in modern drug discovery. In the context of the pyrrolidine ring, a C-4 fluorine atom adjacent to the nitrogen exerts several well-documented effects:

• Conformational bias: The gauche effect between the C–F bond and the adjacent C–N bond stabilises specific ring conformations, which can improve target complementarity and reduce entropic penalties upon binding.
• Metabolic stabilisation: Fluorine at an aliphatic position can block cytochrome P450-mediated oxidation at or near the substituted carbon, potentially extending compound half-life.
• Inductive modulation of basicity: The strongly electronegative fluorine atom lowers the pK_a of the pyrrolidine nitrogen, which can influence membrane permeability and protein-binding profiles.
• Lipophilicity fine-tuning: Unlike many polar substituents, fluorine contributes minimally to polar surface area while subtly modulating logP, assisting in balancing permeability and solubility.

These properties make cis-4-fluoropyrrolidin-3-ol hydrochloride a valuable intermediate when the research goal is to introduce a fluorinated, conformationally defined pyrrolidine into a drug candidate.

Synthetic Utility and Derivatization Strategies

As a bifunctional building block, cis-4-fluoropyrrolidin-3-ol hydrochloride offers two orthogonal reactive sites that can be exploited sequentially or selectively:

N-functionalization: The secondary amine nitrogen (liberated from the hydrochloride salt by treatment with base) can participate in reductive amination, acylation, sulfonylation, Buchwald–Hartwig amination, and other standard N-alkylation protocols. This permits rapid construction of diverse amine libraries from a single stereodefined core.

O-functionalization: The C-3 hydroxyl group can be alkylated, acylated, silylated for protection, or converted to a leaving group (e.g., mesylate or tosylate) to enable S_N2 displacement reactions. Inversion at C-3 through mesylation followed by nucleophilic substitution can also provide access to the corresponding trans isomer or other diastereomers.

Fluorine retention: Because C–F bonds on sp³ carbons are generally robust under standard synthetic conditions, the fluorine atom is typically retained throughout downstream chemistry, making the compound a reliable precursor for fluorinated analogues.

These features enable efficient generation of structure–activity relationship (SAR) arrays around the fluoropyrrolidinol core, which is particularly relevant in fragment-based drug discovery and lead optimisation campaigns.

Handling, Storage, and Safety Considerations

Although cis-4-fluoropyrrolidin-3-ol hydrochloride is not classified as a hazardous material under standard reagent categories, good laboratory practice should be observed at all times:

• Storage: Store in a tightly sealed container in a cool, dry location away from light. Hydrochloride salts of secondary amines can absorb atmospheric moisture; desiccant storage is recommended to maintain compound integrity and accurate mass measurement.
• Personal protective equipment: Use appropriate gloves, laboratory coat, and eye protection when handling the solid or any solutions prepared from it.
• Solubility: The hydrochloride salt is expected to exhibit good solubility in water and polar protic solvents (e.g., methanol, DMSO). For anhydrous reactions, the free base can be liberated by treatment with an appropriate base (e.g., triethylamine, K₂CO₃) prior to use.
• Stability: No specific stability concerns beyond standard amine salt handling are anticipated; however, prolonged exposure to strong oxidants or highly acidic or basic conditions should be avoided.

Researchers should consult the product Safety Data Sheet (SDS) for compound-specific hazard data and confirm local regulatory requirements before use.

Applications in Drug Discovery and Chemical Biology

Fluorinated pyrrolidine scaffolds are encountered across multiple therapeutic areas, reflecting the broad utility of the pyrrolidine ring as a bioisostere for proline and as a conformationally constrained amine fragment. cis-4-Fluoropyrrolidin-3-ol hydrochloride is specifically suited to the following research contexts:

• Protease inhibitor design: Proline mimetics incorporating fluorine are used to probe active-site geometry and improve selectivity in serine and cysteine protease inhibitors.
• Fragment-based drug discovery (FBDD): The low molecular weight, defined stereochemistry, and bifunctionality of this compound make it an attractive fragment for growing or linking strategies.
• PROTAC and bifunctional molecule synthesis: The secondary amine and hydroxyl group serve as anchoring or linker-attachment points in the design of proteolysis-targeting chimeras and other bifunctional degrader molecules.
• Probe compound synthesis: Fluorine-containing pyrrolidinols are used as pharmacological tools to study target engagement, where the fluorine atom may also facilitate ¹⁹F NMR-based binding assays or enable PET tracer development when isotopically labelled analogues are sought.

By incorporating cis-4-fluoropyrrolidin-3-ol hydrochloride into synthetic routes, researchers gain access to a stereodefined, metabolically informed, and pharmacophore-rich building block that accelerates structure–activity studies.